PROTAC BRD4 Degrader-13 is a von Hippel-Lindau (VHL)-based PROTAC BRD4 degrader designed to be conjugated via a linker to antibodies (e.g., STEAP1 and CLL1 antibodies) to form PROTAC-antibody conjugates (PACs); it effectively degrades BRD4 protein in PC3 prostate cancer cells with DC50 values of 0.025 nM and 6.0 nM when conjugated to STEAP1 and CLL1 antibodies, respectively.